These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7593132)

  • 41. Levels of insulin-like growth factor (IGF) binding proteins, luteinizing hormone and IGF-I receptors, and steroids in dominant follicles during the first follicular wave in cattle exhibiting regular estrous cycles.
    Stewart RE; Spicer LJ; Hamilton TD; Keefer BE; Dawson LJ; Morgan GL; Echternkamp SE
    Endocrinology; 1996 Jul; 137(7):2842-50. PubMed ID: 8770905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study.
    Ho GH; Ji CY; Phang BH; Lee KO; Soo KC; Ng EH
    Ann Surg Oncol; 1998 Jun; 5(4):361-7. PubMed ID: 9641459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between serum insulinlike growth factor-1, insulinlike growth factor binding protein-2, and insulinlike growth factor binding protein-3 and nutritional intake in premature infants with bronchopulmonary dysplasia.
    Price WA; Lee E; Maynor A; Stiles AD; Clemmons DR
    J Pediatr Gastroenterol Nutr; 2001 May; 32(5):542-9. PubMed ID: 11429514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.
    Karna E; Surazynski A; Orłowski K; Łaszkiewicz J; Puchalski Z; Nawrat P; Pałka J
    Int J Exp Pathol; 2002 Oct; 83(5):239-45. PubMed ID: 12641820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IGF status is altered by tamoxifen in patients with breast cancer.
    Campbell MJ; Woodside JV; Secker-Walker J; Titcomb A; Leathem AJ
    Mol Pathol; 2001 Oct; 54(5):307-10. PubMed ID: 11577172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of breast surgery on serum levels of insulin-like growth factors (IGF-I, IGF-II, and IGF binding protein-3) in women with benign and malignant breast lesions.
    Holdaway IM; Lethaby AE; Mason BH; Singh V; Harman JE; MacCormick M; Civil ID
    Ann Surg Oncol; 2001; 8(1):25-31. PubMed ID: 11206220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of physical activity on plasma insulin-like growth factor-1 and insulin-like growth factor binding proteins in healthy older women.
    Chadan SG; Dill RP; Vanderhoek K; Parkhouse WS
    Mech Ageing Dev; 1999 Jun; 109(1):21-34. PubMed ID: 10405986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells.
    Ahmed SR; Manni A; Gray G; Hammond JM
    Anticancer Res; 1990; 10(5A):1217-23. PubMed ID: 1700662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
    Miraki-Moud F; Jenkins PJ; Fairclough PD; Jordan S; Bustin SA; Jones AM; Lowe DG; Monson JP; Grossman AB; Besser GM; Camacho-Hübner C
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):499-508. PubMed ID: 11318786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-related changes in serum levels of insulin-like growth factor-II and its binding proteins correlate with calcaneal bone mineral density among post-menopausal South-Indian women.
    Sittadjody S; Ilangovan R; Thangasamy T; Vignesh RC; Veni S; Bertoni AG; Srinivasan S; Subramanian C; Srinivasan N
    Clin Chim Acta; 2012 Dec; 414():281-8. PubMed ID: 23041218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women.
    Vadgama JV; Wu Y; Datta G; Khan H; Chillar R
    Oncology; 1999 Nov; 57(4):330-40. PubMed ID: 10575321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure of vascular allografts to insulin-like growth factor-I (IGF-I) increases vascular expression of IGF-I ligand and receptor protein and accelerates arteriosclerosis in rats.
    Motomura N; Lou H; Orskov H; Ramwell PW; Foegh ML
    Transplantation; 1998 Apr; 65(8):1024-30. PubMed ID: 9583860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum concentrations of IGF-I, estradiol-17beta, testosterone, and relative amounts of IGF binding proteins (IGFBP) in growing boars, barrows, and gilts.
    Clapper JA; Clark TM; Rempel LA
    J Anim Sci; 2000 Oct; 78(10):2581-8. PubMed ID: 11048923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.